Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1926 1
1929 1
1941 1
1944 1
1945 2
1946 5
1947 6
1948 3
1949 1
1950 1
1951 2
1953 2
1955 3
1956 1
1957 3
1958 3
1959 2
1962 2
1964 1
1965 7
1966 2
1967 5
1968 2
1969 5
1970 4
1971 4
1972 5
1973 3
1974 1
1975 3
1976 1
1977 4
1978 4
1979 4
1980 4
1981 4
1982 2
1983 1
1984 5
1985 8
1986 4
1987 13
1988 3
1989 9
1990 3
1991 6
1992 7
1993 7
1994 12
1995 18
1996 21
1997 17
1998 18
1999 22
2000 27
2001 27
2002 28
2003 35
2004 46
2005 31
2006 24
2007 34
2008 38
2009 47
2010 46
2011 59
2012 60
2013 54
2014 49
2015 57
2016 52
2017 39
2018 37
2019 54
2020 46
2021 61
2022 44
2023 39
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,222 results

Results by year

Filters applied: . Clear all
Page 1
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes.
Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder RE, Anker SD, Filippatos G, Pitt B, Rossing P, Lambelet M, Nowack C, Kolkhof P, Joseph A, Bakris GL. Agarwal R, et al. Among authors: haller h. J Hypertens. 2023 Feb 1;41(2):295-302. doi: 10.1097/HJH.0000000000003330. Epub 2022 Dec 8. J Hypertens. 2023. PMID: 36583355 Free PMC article. Clinical Trial.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group. Bakris GL, et al. Among authors: haller h. JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081. JAMA. 2015. PMID: 26325557 Clinical Trial.
[Hypertension].
Haller H. Haller H. Internist (Berl). 2021 Mar;62(3):221-222. doi: 10.1007/s00108-021-00978-2. Epub 2021 Feb 25. Internist (Berl). 2021. PMID: 33630112 German. No abstract available.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: haller h. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
[What is proven in treatment?].
Haller H, Schmidt-Ott K. Haller H, et al. Inn Med (Heidelb). 2023 Dec;64(12):1133-1134. doi: 10.1007/s00108-023-01633-8. Epub 2023 Nov 23. Inn Med (Heidelb). 2023. PMID: 37994933 German. No abstract available.
[Genetics in medicine].
Haller H, Hasenfuß G, Schäfer JR. Haller H, et al. Internist (Berl). 2018 Aug;59(8):753-755. doi: 10.1007/s00108-018-0463-9. Internist (Berl). 2018. PMID: 30039391 German. No abstract available.
[Herbal medicines for psychiatric disorders].
Anheyer D, Haller H, Klose P, Cramer H, Dobos G. Anheyer D, et al. Among authors: haller h. Nervenarzt. 2018 Sep;89(9):1009-1013. doi: 10.1007/s00115-018-0539-8. Nervenarzt. 2018. PMID: 29846749 Review. German.
1,222 results